When the neuroleptics-are-necessary-to-treat-schizophrenia myth falls, psychiatry is finished. And that is why the Goff et al paper was produced: a desperate attempt to maintain its position by a profession that is truly on the ropes. For psychiatry this is a death-struggle.
Individuals with lived experience and clinicians share about barriers and facilitators to guided self-help CBT for voice hearing.
From National Post: Many physicians are prescribing a low dose of Seroquel, an atypical antipsychotic, to patients with insomnia. Experts warn that even a low...
From Reuters: Two youth legal advocacy groups have filed a lawsuit against Missouri for over-exposing foster children to psychotropic drugs. The lawsuit seeks a court...
Evidence of duplicate publishing in articles analyzing data from clinical trials testing second-generation antipsychotics for depression
Veterans diagnosed with PTSD and taking SSRIs, novel antidepressants, or atypical antipsychotics are more likely to develop dementia.
Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.
Higher levels of sedentary behavior are associated with poorer cognitive functioning in patients diagnosed with schizophrenia.
From Healio: Researchers recently found that veterans diagnosed with PTSD and prescribed antidepressants or atypical antipsychotics are at a higher risk for dementia than veterans...
From Aeon: While psychiatric drugs are often ineffective and can have serious side effects, there are many psychedelics and other illicit substances that have proven...
Important assessment tool found to underestimate the risk for fracture in patients on psychiatric medication.
The most worrying thing about the Goff et al paper is the minimisation of the evidence that antipsychotics produce brain shrinkage. There are no studies that show progressive brain changes in people diagnosed with schizophrenia or psychosis in the absence of antipsychotic treatment.
A new study published in JAMA Internal Medicine, the largest study of its kind, has shown it is possible to reduce the use of antipsychotics in nursing homes, by engaging their staff in a training program designed to target residents’ strengths and their unmet needs.
From Scientific American: Many autistic children are prescribed multiple psychiatric medications, which can lead to serious adverse effects and are often ineffective. "Multiple diagnoses lead to...
A new study finds that for those experiencing symptoms associated with psychosis, a low-level of physical activity is associated with receiving a diagnosis of a psychotic disorder.
In this piece for The Cut, Dyan Neary details the story of Frankie Perry, a man whose life was forever altered by being prescribed an...
Reduced usage of antipsychotics in first-episode psychosis was associated with improved executive functioning.
Researchers found that veterans with both conditions had higher odds of being prescribed second-generation antipsychotics than those presenting with just PTSD.
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
A meta-analysis of known risk factors for psychosis finds elevated risk with the presence of childhood trauma, adverse life events, and affective dysfunction.
A review article and meta-analysis of 18 articles published in the journal of Psychological Medicine reported effects of vitamin and/or mineral supplements on psychiatric symptoms in people diagnosed with schizophrenia. The study provides evidence of the beneficial effects of taking certain vitamins and minerals for improving symptoms associated with schizophrenia.
The American Psychological Association (APA) recently published a study finding that patients assigned to drug-only treatments were more likely to refuse treatment, and more likely to drop out before treatment completion, than patients assigned to psychotherapy only.
From Daily Mail: The anti-psychotic drug Abilify is at the center of hundreds of lawsuits accusing the drug of dangerous side effects including compulsive gambling,...
Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease have failed
Despite little evidence for benefit, and substantial risk of harm, antipsychotics are commonly prescribed to children diagnosed with ADHD